IFNG and neoplasm: The DOX and R837 co-delivering hydrogel effectively inhibited in vivo tumor growth and metastatic progression through DOX-based ICD, with R837-based immune response amplification through DC maturation, M1 macrophage activation, tumor necrosis factor-α (TNF-α), and IFN-γ secretion.